May 2006
Volume 47, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2006
Changes in Retinal Blood Velocity in Response to Modulation of the Intraretinal Nitric Oxide Level
Author Affiliations & Notes
  • J.J. Kang Derwent
    Dept of Biomedical Engineering, Illinois Institute of Technology, Chicago, IL
  • K. Lorentz
    Dept of Biomedical Engineering, Illinois Institute of Technology, Chicago, IL
  • S. Tummala
    Dept of Biomedical Engineering, Illinois Institute of Technology, Chicago, IL
  • Footnotes
    Commercial Relationships  J.J. Kang Derwent, None; K. Lorentz, None; S. Tummala, None.
  • Footnotes
    Support  The Whitaker Foundation
Investigative Ophthalmology & Visual Science May 2006, Vol.47, 1792. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      J.J. Kang Derwent, K. Lorentz, S. Tummala; Changes in Retinal Blood Velocity in Response to Modulation of the Intraretinal Nitric Oxide Level . Invest. Ophthalmol. Vis. Sci. 2006;47(13):1792.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : The present study was undertaken to determine the effect of modulating intraretinal nitric oxide (NO) levels on retinal blood velocity using a Scanning Laser Ophthalmoscope (SLO).

Methods: : Retinal blood velocity was determined by tracking 1 µm yellow–green fluorescent microspheres (505 nm maximum absorption and 515 nm maximum emission) in anesthetized pigmented adult rats. Using the SLO, retinal blood velocities were obtained in arteries, veins, and small vessels by recording several 2–min digital movies at each time point. Directional flow of fluorescent microspheres and vessel characterization were determined based on examination of infrared reflectance and fluorescein angiogram images. The NO levels were modulated by one 3 µl intravitreal injections of either nitric oxide synthase (NOS) inhibitors, NG–nitro–L– arginine methyl ester (L–NAME, 2.5 mM vit. conc, eNOS inhibitor) and 1–(2–trifluoromethylphenyl) imidazole (TRIM, 2 mM vit. conc, nNOS inhibitor) or a NO donor, S–nitroso–N–acetylpenicilliamin (SNAP, 2 mM vit. conc). Intraocular pressure (IOP) was measured before and after the injection. Post–treatment velocity measurements were obtained every 15 minutes for ∼2 hours after the injection.

Results: : Neither changes in image quality nor changes in IOP were observed with the intravitreal injections. No change in heart rate was observed after the injection. After L–NAME treatment, overall blood velocity decreased compared to the control values. Arterial velocity decreased by ∼15%, venous velocity decreased by ∼36% and small vessel velocity decreased by ∼26%. TRIM treatment increased arterial velocity by ∼15%, venous velocity by ∼20% and small vessel velocity by ∼5%. SNAP treatment also increased arterial velocity by ∼28% and venous velocity by ∼13%.

Conclusions: : These findings suggest that intravitreal administration of the pharmacological agents had selective local effects on the retina. Changes in blood velocity due to the neuronal NOS inhibitor suggest that neuronal NOS may also be involved in controlling blood flow in the retina.

Keywords: blood supply • nitric oxide 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×